Skip to main navigation Skip to search Skip to main content

Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention

  • Sebastian Brings
  • , Thomas Fleming
  • , Marc Freichel
  • , Martina U. Muckenthaler
  • , Stephan Herzig
  • , Peter P. Nawroth
  • Universitätsklinikum Heidelberg
  • German Centre for Diabetes Research (DZD)
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Heidelberg University

Research output: Contribution to journalReview articlepeer-review

191 Scopus citations

Abstract

Advanced glycation end-products (AGEs) are non-enzymatic protein and amino acid adducts as well as DNA adducts which form from dicarbonyls and glucose. AGE formation is enhanced in diabetes and is associated with the development of diabetic complications. In the current review, we discuss mechanisms that lead to enhanced AGE levels in the context of diabetes and diabetic complications. The methylglyoxal-detoxifying glyoxalase system as well as alternative pathways of AGE detoxification are summarized. Therapeutic approaches to interfere with different pathways of AGE formation are presented.

Original languageEnglish
Article number984
JournalInternational Journal of Molecular Sciences
Volume18
Issue number5
DOIs
StatePublished - 5 May 2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 3-deoxyglucosone
  • Advanced glycation end-products
  • Aldose reductase
  • Diabetes
  • Glyoxal
  • Glyoxalase
  • Methylglyoxal

Fingerprint

Dive into the research topics of 'Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention'. Together they form a unique fingerprint.

Cite this